Compare HLIT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLIT | MDXG |
|---|---|---|
| Founded | 1988 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 1995 | N/A |
| Metric | HLIT | MDXG |
|---|---|---|
| Price | $10.46 | $7.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $13.13 | $12.00 |
| AVG Volume (30 Days) | ★ 1.1M | 774.9K |
| Earning Date | 11-03-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.43 | 0.27 |
| Revenue | ★ $635,710,000.00 | $393,442,000.00 |
| Revenue This Year | N/A | $19.13 |
| Revenue Next Year | $21.80 | $2.11 |
| P/E Ratio | ★ $24.18 | $26.77 |
| Revenue Growth | 1.93 | ★ 14.77 |
| 52 Week Low | $7.80 | $5.79 |
| 52 Week High | $13.75 | $9.71 |
| Indicator | HLIT | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 59.83 | 52.88 |
| Support Level | $10.10 | $6.62 |
| Resistance Level | $10.75 | $7.30 |
| Average True Range (ATR) | 0.31 | 0.23 |
| MACD | 0.14 | 0.04 |
| Stochastic Oscillator | 80.94 | 71.11 |
Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.